A major concern with cannabis‐based medicines (CbM) and medical cannabis (MC) is the risk of abuse and dependence. The face validity of the International Classification of Diseases (ICD‐10) criteria for… Click to show full abstract
A major concern with cannabis‐based medicines (CbM) and medical cannabis (MC) is the risk of abuse and dependence. The face validity of the International Classification of Diseases (ICD‐10) criteria for cannabis dependence in patients prescribed CbM for chronic pain has not been assessed.
               
Click one of the above tabs to view related content.